That is odd they could get their CS disinfectant approved. We tried in 1999, and were unsuccessful. A disinfectant must kill everything, including spores, within a short timeframe. CS does not touch spores without germinating them, and germinating them takes longer than the amount of time a disinfectant must work to meet the requirements.
I wonder if they changed the requirements, or if some money changes hands somewhere. Marshall [email protected] wrote: > > > Hello List, > > Clifton Mining (CFTN-OTC) and American Biotech produce a colloidal > silver compound that arrests the effects of malaria. The mosquito-born > fever kills 2.7 million people a year, mostly African children. The > world spends $300 million a year on malaria control and a WHO progress > report on the $700 million Roll Back Malaria campaign conducted over > the past two years has achieved little. UN Secretary General Kofi > Annan is from Ghana, where successful tests have been completed, which > in hospital trials shows that American Biotech and Clifton Mining's > colloidal silver product ASAP arrests the effects of malaria. The two > companies' representative met this week with WHO executives to discuss > the possible use of ASAP via the World Health Organization. Malaria > costs the African economy $12 billion a year. > > Clifton Mining Company (OTC: CFTN) > Alpine, Utah: November 11th, 2002. Clifton Mining Company (OTC: CFTN) > is pleased to announce that American Biotech Labs, a company in which > Clifton owns approximately 30% has finished the approval process with > the U.S. EPA and expects to get full hospital approval in the next few > weeks. > > The Testing > > In the test work for the EPA hospital approval, the ASAP Solution® > had to kill hundreds of thousands of some of the deadliest types of > bacteria found in the United States within minutes, and it proved able > to do so. There were approximately 1600 individual bacterial tests in > just one series alone. American Biotech's product was able to pass all > the tests. > > The Hospital Approval > > American Biotech Labs expects to get the full hospital disinfectant > approval within the next 15-45 days. The approval will open the door > to sell the highly effective, yet non-toxic disinfectant to thousands > of hospitals, clinics, rest homes, and other healthcare facilities > worldwide. Management expects sales of the new disinfectant to > possibly begin as soon as January 2003. Said Keith Moeller, V.P., > "This will be a very important product for the market. Because this > product is non-toxic and yet highly effective at killing even the MRSA > super bacteria, we expect sales to boom worldwide. Unlike other > disinfectants, this product can be used in and around patients to kill > bacteria with no adverse effect. It is so safe that it could be > sprayed right on the skin or even consumed orally with no adverse > consequences." > > Malaria Testing/Drug Approval > > A new human trial specifically testing ASAP's effectiveness on malaria > is under way in Ghana, West Africa. In the first two tests, 19 people > who had been diagnosed with malaria were treated with the ASAP > Solution. All 19 people (mostly children) were reported by the doctors > as being fully recovered within just seven days. The latest malaria > tests should be completed within the next 60 days. With no reported > failures, the human tests have gone so well that the official Food and > Drug Board of Ghana has already approved the ASAP Solution® for drug > registration. Recent West African trials also tested the product as a > treatment for fungal skin infections, vaginal infections, urinary > tract infections, tonsillitis, pharingitis, some sexually transmitted > diseases, conjunctivitis, upper respiratory tract infections, nasal > and sinus problems, etc. In almost every human case tested so far, > full recovery was reached in just 1-7 days. > > http://www.kitco.com/ind/Chapman/nov122002.html > > Michael > > > > > >
